| Application no. and date | 10701175.1 (espacenet) (Federated) (European Patent Register), 20100115 | | Patent/reg. no. and date | DK/EP 2387563, 20130306 | | Publication date | 20111123 | | Priority no. and date | US 145421 P, 20090116 | | EP pub. no. and date |
EP 2387563 20111123 | | Effective date | | | Applicant/owner | Exelixis, Inc., 210 East Grand Avenue
P.O. Box 511
South San Francisco, CA 94080-0511, US | | Applicant ref. no. | P229232DKEP | | Inventor | LAMB, Peter, 814 Mandana Blvd.
Oakland
CA 94610, US,
GALLAGHER, William, P., P.O. Box 4000
Princeton
NJ 08543, US,
BROWN, Adrian St. Clair, 67 Stour Green
Ely, Cambridgeshire CB6 2XJ, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/47 (2006.01) , A61P 35/00 (2006.01) , C07D 215/227 (2006.01) | | Title | MALATSALT AF N-(4-{ [ 6, 7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL-N'-(4-FLUORPHENYL)CYCLOPROPAN-1,1-DICARBOXAMID, OG KRYSTALLINSKE FORMER DERAF TIL BEHANDLING AF CANCER | | Int. application no. | US2010021194 | | Int. publication no. | WO2010083414 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
